3.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SGHT Giù?
Forum
Previsione
Precedente Chiudi:
$3.22
Aprire:
$3.17
Volume 24 ore:
6,118
Relative Volume:
0.03
Capitalizzazione di mercato:
$142.68M
Reddito:
$81.06M
Utile/perdita netta:
$-55.55M
Rapporto P/E:
-2.7807
EPS:
-1.14
Flusso di cassa netto:
$-47.98M
1 W Prestazione:
+14.86%
1M Prestazione:
+24.31%
6M Prestazione:
-41.19%
1 anno Prestazione:
-39.96%
Sight Sciences Inc Stock (SGHT) Company Profile
Nome
Sight Sciences Inc
Settore
Industria
Telefono
(415) 889-0550
Indirizzo
4040 CAMPBELL AVE,, MENLO PARK
Confronta SGHT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
SGHT
Sight Sciences Inc
|
3.18 | 142.68M | 81.06M | -55.55M | -47.98M | -1.14 |
![]()
ABT
Abbott Laboratories
|
129.34 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
102.39 | 138.41B | 17.55B | 2.03B | 2.37B | 1.37 |
![]()
SYK
Stryker Corp
|
367.17 | 129.62B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
84.21 | 107.92B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
76.30 | 40.53B | 5.54B | 4.18B | 259.90M | 7.00 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-06 | Iniziato | UBS | Buy |
2024-11-04 | Downgrade | Lake Street | Buy → Hold |
2024-08-21 | Iniziato | Lake Street | Buy |
2023-09-12 | Downgrade | BofA Securities | Neutral → Underperform |
2023-09-12 | Downgrade | Piper Sandler | Overweight → Neutral |
2023-09-12 | Downgrade | William Blair | Outperform → Mkt Perform |
2023-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2023-07-10 | Downgrade | Citigroup | Buy → Neutral |
2023-01-06 | Aggiornamento | Stifel | Hold → Buy |
2022-10-04 | Iniziato | Needham | Hold |
2022-07-26 | Iniziato | Stifel | Hold |
2022-02-03 | Iniziato | William Blair | Outperform |
2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Sight Sciences Inc Borsa (SGHT) Ultime notizie
Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times
Sight Sciences, Inc. to Report First Quarter Financial Results on May 8, 2025 - Nasdaq
Eyecare Tech Leader Sight Sciences Sets Q1 2025 Earnings Date: What Investors Should Watch - Stock Titan
Sight Sciences (SGHT) to Release Earnings on Thursday - Defense World
Sight Sciences Announces the Release of its Sustainability Report - GlobeNewswire
Sight Sciences Sustainability Report Reveals Strong Gender Pay Equity, 14% Staff Retention Boost - Stock Titan
Sight Sciences Appoints Gary Burbach to Board of Directors - VisionMonday.com
Sight Sciences appoints new board member By Investing.com - Investing.com India
Sight Sciences appoints new board member - Investing.com
Sight Sciences Appoints Gary Burbach to its Board of Directors - The Manila Times
Sight Sciences Strengthens Board with Medtech Veteran as Glaucoma, Dry Eye Markets Transform - Stock Titan
Sight Sciences Launches OMNI® Edge Surgical System to Enhance Glaucoma Treatment - Nasdaq
Sight Sciences to Debut OMNI® Edge Surgical System at the - GlobeNewswire
Sight Sciences Unveils OMNI Edge: Next-Gen Glaucoma Surgery System with 2X Capacity | SGHT Stock News - Stock Titan
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Acquired by American Century Companies Inc. - Defense World
Sight Sciences (NASDAQ:SGHT) Earns Hold Rating from Needham & Company LLC - Defense World
Sight sciences CTO David Badawi sells $15,081 in stock - MSN
April 2025's Top Penny Stocks To Watch - simplywall.st
Sight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Sight Sciences at 24th Annual Needham Conference: Strategic Growth Insights - Investing.com Canada
Sight sciences chief commercial officer sells $11,641 in stock By Investing.com - Investing.com India
Sight Sciences stock hits 52-week low at $2.13 amid market challenges - Investing.com
Sight sciences chief commercial officer sells $11,641 in stock - Investing.com
Sight sciences CEO Paul Badawi sells shares worth $55,672 By Investing.com - Investing.com Australia
Sight sciences CTO David Badawi sells $13,771 in common stock By Investing.com - Investing.com India
Sight Sciences CFO Alison Bauerlein sells shares worth $44,787 By Investing.com - Investing.com Australia
Sight Sciences CFO Alison Bauerlein sells shares worth $44,787 - Investing.com
Sight sciences CTO David Badawi sells $13,771 in common stock - Investing.com
Sight Sciences chief legal officer sells $21,693 in stock - Investing.com
Sight Sciences chief legal officer sells $21,693 in stock By Investing.com - Investing.com UK
Sight Sciences Executives Sell Shares to Cover Tax Liabilities - TradingView
Sight Sciences stock hits 52-week low at $2.13 amid market challenges By Investing.com - Investing.com South Africa
Sight Sciences, Inc. (NASDAQ:SGHT) Short Interest Update - Defense World
Charles Schwab Investment Management Inc. Raises Stock Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Looks Inexpensive But Perhaps Not Attractive Enough - simplywall.st
Sight sciences chief legal officer sells shares worth $19,250 - MSN
Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th - GlobeNewswire
Key Investor Updates Coming: Sight Sciences Takes Center Stage at Major Healthcare Conference - Stock Titan
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of “Hold” from Analysts - Defense World
Sight sciences EVP Manohar Raheja buys $53,250 in stock By Investing.com - Investing.com Australia
Sight sciences EVP Manohar Raheja buys $53,250 in stock - Investing.com India
Piper Sandler Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $3.50 - Defense World
Sight Sciences’ (SGHT) Hold Rating Reiterated at Needham & Company LLC - Defense World
Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics - MSN
Lake Street Capital Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World
Stifel Nicolaus Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World
Earnings call transcript: Sight Sciences Q4 2024 results miss forecasts By Investing.com - Investing.com Australia
Actinic Keratosis Market Forecast 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Treatment, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail
Sight Sciences Inc. (SGHT) reports earnings - Quartz
Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results, Initiates Full Year 2025 Financial Guidance - Vision Monday
Sight Sciences Inc Azioni (SGHT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):